Related Experiment Videos
Venous thrombosis: antithrombin III deficiency
Critical Care Nursing Clinics of North America
|September 1, 1993
Summary
Antithrombin (ATIII) deficiency significantly increases the risk of venous thrombosis due to its role as a natural anticoagulant. This review covers the pathophysiology, clinical signs, diagnosis, and treatment of this condition.
Area of Science:
- Biochemistry
- Hematology
- Pathophysiology
Background:
- Antithrombin (ATIII) is a critical natural anticoagulant protein.
- ATIII deficiency predisposes individuals to a high risk of venous thrombosis.
Observation:
- Individuals with ATIII deficiency demonstrate a marked propensity for developing venous thromboembolic events.
- The pathophysiology involves impaired regulation of coagulation factors.
Findings:
- Understanding the pathophysiology of ATIII deficiency is key to managing thrombotic risk.
- Clinical presentation can vary, necessitating accurate diagnostic approaches.
Implications:
- Effective diagnosis and treatment strategies are crucial for patients with ATIII deficiency.
- Management aims to prevent recurrent thrombotic events and improve patient outcomes.